Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5-6
|
pubmed:dateCreated |
1994-9-29
|
pubmed:abstractText |
We investigated the expression of the lymphocyte function associated (LFA)-1 adhesion molecule, recognized by the CD11a and CD18 monoclonal antibodies, in 53 patients with B-cell chronic lymphocytic leukemia (B-CLL) and in 37 controls. The mean percentage of control lymphocytes expressing CD11a and CD18 positivity was 92 +/- 5.5 and 90 +/- 8.7, respectively and, in patients with B-CLL, 14.2 +/- 10.3 and 14.8 +/- 10.3 respectively (p < 0.001). No statistical difference was found between CD11a and CD18 expression and the Rai clinical stages. In our experience a decrease of LFA-1 is a constant finding in B-CLL, in the early stages of the disease. It may, therefore, be useful to differentiate between slight increases of neoplastic cells and reactive blood lymphocytosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
1042-8194
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
13
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
457-61
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7915162-Antigens, CD,
pubmed-meshheading:7915162-Antigens, CD18,
pubmed-meshheading:7915162-Humans,
pubmed-meshheading:7915162-Immunophenotyping,
pubmed-meshheading:7915162-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:7915162-Lymphocyte Function-Associated Antigen-1,
pubmed-meshheading:7915162-Neoplasm Staging
|
pubmed:year |
1994
|
pubmed:articleTitle |
Expression of lymphocyte function-associated antigen (LFA)-1 in B-cell chronic lymphocytic leukemia.
|
pubmed:affiliation |
Hematology and Oncology Unit 1973, Hospital Central de L'Aliança, Barcelona, Spain.
|
pubmed:publicationType |
Journal Article
|